Literature DB >> 810150

Primary intestinal lymphoma and its relation to alpha heavy chain disease.

B Ramot, N Hulu.   

Abstract

Primary intestinal lymphoma in young adults is a disease that occurs mainly in underprivileged populations. There is evidence that in some cases this disease evolves from a benign lymphoplasmocytic infiltration of the gut with alpha heavy chain. More studies are needed on the effect of environmental and genetic factors on the evolution of this disease. The role of oncogenic viruses in the development of intestinal lymphoma with malabsorption is an open question. Regional studies on the entity of intestinal lymphoma with malabsorption and its relationship to childhood lymphoma in the same populations are warranted.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 810150      PMCID： PMC2149557     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN： 0306-9443


  22 in total

1.  MALABSORPTION SYNDROME WITH MALIGNANT LYMPHOMA.

Authors:  T H KENT
Journal:  Arch Pathol       Date:  1964-08

2.  Lymphoma of the stomach and intestine.

Authors:  J F SKRIMSHIRE
Journal:  Q J Med       Date:  1955-07

3.  The sprue syndrome secondary to lymphoma of the small bowel.

Authors:  M H SLEISENGER; T P ALMY; D P BARR
Journal:  Am J Med       Date:  1953-11       Impact factor: 4.965

4.  Childhood non-Hodgkin's lymphoma--a study of 17 cases in Israel.

Authors:  E Aghai; N Hulu; I Virag; G Kende; B Ramot
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

5.  Neoplasia and the coeliac syndrome in adults.

Authors:  P W Brunt; W Sircus; N Maclean
Journal:  Lancet       Date:  1969-01-25       Impact factor: 79.321

6.  Malignancy in adult coeliac disease and idiopathic steatorrhoea.

Authors:  O D Harris; W T Cooke; H Thompson; J A Waterhouse
Journal:  Am J Med       Date:  1967-06       Impact factor: 4.965

7.  Childhood abdominal lymphoma in Israel.

Authors:  N Hulu; B Ramot; W Sheehan
Journal:  Isr J Med Sci       Date:  1970 Mar-Apr

8.  Lymphoreticular dysfunction in idiopathic steatorrhoea.

Authors:  C F McCarthy; I D Fraser; K T Evans; A E Read
Journal:  Gut       Date:  1966-04       Impact factor: 23.059

9.  Intestinal lymphoma and sprue: a systematic approach.

Authors:  W Dutz; S Asvadi; S Sadri; E Kohout
Journal:  Gut       Date:  1971-10       Impact factor: 23.059

10.  Intestinal reticulosis as a complication of idiopathic steatorrhoea.

Authors:  K R GOUGH; A E READ; J M NAISH
Journal:  Gut       Date:  1962-09       Impact factor: 23.059
View more
  8 in total

1.  Alpha heavy chain disease (report of 18 cases from Iraq).

Authors:  Z Al-Bahrani; T Al-Saleem; H Al-Mondhiry; F Bakir; H Yahia; I Taha; J King
Journal:  Gut       Date:  1978-07       Impact factor: 23.059

Review 2.  Malignant lymphomas--a conceptual understanding of morphologic diversity. A review.

Authors:  R B Mann; E S Jaffe; C W Berard
Journal:  Am J Pathol       Date:  1979-01       Impact factor: 4.307

Review 3.  Advances in management of non-Hodgkin lymphoma.

Authors:  T S Vats
Journal:  Indian J Pediatr       Date:  1987 Nov-Dec       Impact factor: 1.967

4.  Alpha-chain disease in an Englishman.

Authors:  S W Wang
Journal:  Postgrad Med J       Date:  1976-12       Impact factor: 2.401

5.  Primary intestinal lymphomas.

Authors:  H F Otto; I Bettmann; J V Weltzien; J O Gebbers
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

6.  Alpha-chain disease and its association with intestinal lymphoma.

Authors:  A Kharazmi; P Haghighi; M Haghshenas; K Nasr; P Abadi; H R Rezai
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

7.  ["Malabsorptive" dermatitis herpetiformis. A study with particular regard to biopsy findings of the small intestine (author's transl)].

Authors:  H F Otto; J Sack; J O Gebbers; K H Schulz; K Müller-Wieland
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-07-31

8.  T and B lymphocytes in alpha-chain disease.

Authors:  A Kharazmi; M H Rezai; P Abadi; K Nasr; P Haghighi; M Haghshenas
Journal:  Br J Cancer       Date:  1978-01       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.